ABT vs CSGS · P/E 25, rev $44.33B vs P/E 22, rev $1.20B
Abbott Laboratories (ABT) versus CSG Systems International Inc (CSGS) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
CSG Systems International Inc (CSGS) is a software - infrastructure company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported CSGS revenue for 2024-12-31 was $1.20B. Net income was $86.9M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. CSGS currently screens at market cap $1.84B and trailing P/E 21.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. CSGS currently screens at market cap $1.84B and trailing P/E 21.8.
Not investment advice. Open the ABT and CSGS stock pages for the full models.
Not investment advice.